Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
good luck !
another blood red day here...
Just have to know to trade at the right time
the pps was cut in half in one year...
Jul 20 2020 172.34
doesn't appear anything here was " delicious "....lol..
Not at all, just the opposite!
The ceo is a turd sandwich however!
Funny cause those 65s were delicious
for sure, dead money walking......
this stock is a pos.....and everyone knows it..
Looking like we should test the 80s did you read the latest from q2?
I’m young and know someone with MD.
Yikes...well good luck to us all.
I’m loaded
I’m stupid but i put my entire IRA into this avg 71 now. Hoping it pays off in a big way.
Indeed along with a couple nice upgrades. Sold a few I bought earlier had to take advantage.
My long term shares are safely tucked away.
Literally nothing has changed from 89 to 66. Crazy.
Same 300 shares today at 67.20
FDA getting beat up pretty good.
Last five days have been horrible for SRPT
Also buying below 67
They had decent press a couple weeks ago.
Weird.
"Well....here at 66+ I just bought some more shares. Awful chart don't see anything company specific but most bios and therapeutics are heading down. Couldn't resist but hope I am not too early. Still think the FDA issue with the Alzheimers approval for BIIB is an issue perception wise.
BWDIK....good luck!"
Well....here at 66+ I just bought some more shares. Awful chart don't see anything company specific but most bios and therapeutics are heading down. Couldn't resist but hope I am not too early. Still think the FDA issue with the Alzheimers approval for BIIB is an issue perception wise.
BWDIK....good luck!
Yep i agree with all of that and i posted that exact thing on another forum
Me too! Would be a big winner.
Good luck!
Still holding rest of my sharers of SRPT....I have noticed two things that might be helping SRPT take place this week.....
BIIB....FDA approval for their Alzheimers drug though controversial but shows some FDA leniency for a change
Rotation into the Bio and Pharma sector as many stocks I follow have bounced.....like GILD for example.
Hoping one day SRPT fills that huge overhead gap.
72 avg looking good. This could go up in a big way.
Early encouraging DMD results from SRPT study 9001-3, conducted in partnership with Roche, were released 5/18/2021. By end of week, share price settled back from ~ $84 to $79.58. RBC price target= $133, per william.alpert@barrons.com
They need to update the 9001 trial that they had the big fall with. Design issue. That would make the biggest diff if good news with that
Sold some of mine in premarket near 73 looks like a good move for now. Guess update wasn't well received...so far.
I am still in buying in small lots down here. All bios and pharmas have taken hits probably due to pricing of drugs chatter.
Average now 76.
Hoping news on Monday starts trend up
Srpt
Thanks good to see you too.
I added a few more in the high 78’s hoping the 52 week low holds up most of the bios and Pharmas on my watchlist were down today.
Good to see you, from $M
I’ve averaged down to 85
890 shares
Good luck, my price target is $130
New position in at $81 even.
Been watching SRPT for a few years now don't understand why analysts are not on this one much especially after recent trial results and ceos positive comments.
Hope I want it.
With the recent approval this stock is extremely undervalued. We will see Monday on ER
New analyst report covering DMD. Great analysis of the market potential.
https://kametresearch.com/dmd-duchenne-muscular-dystrophy-market-analysis/
Not trying to hurt anyone's feelings here but if you are interested in DMD then you need to jump ship from here and head over to CAPR. If you are not familiar with them it won't take you long at all to see that that's where the real progress is being made on DMD.
$CAPR
It's a steady gain. We'll see more recovery tomorrow and all week.
I do like 'dead cat bounce plays" just got through with ARCT on a similar scenario
GLTU
Yup...Been flipping the SH** out of it...
Are you playing the bounce
I believe it is oversold (RSI 15%)
Oh, without a doubt....
I agree, i got in after the plummet, I believe it is oversold (RSI 15%)
Some mixed results from trial.
... big setback, but 50% crash is probably overdone
Picked up a few shares at $80
... and it seems to have found support ~ $83 ???
Not that familiar with pipeline, but looked like mostly similar
programs?
"Wow what happened here?
50% drop, that's insane"
damn did 2 trades here one from 78 to 84.5 and a second at 83 to ????
i agree Sarepta Therapeutics (SRPT)
83.6 ? -82.85 (-49.77%)
Volume: 4,648,590 @01/07/21 7:30:10 PM EST
Bid Ask Day's Range
83.6 84.0 166.93 - 174.04
SRPT Detailed Quote
Wow what happened here?
50% drop, that's insane
Sarepta Therapeutics (SRPT)
128.6101 ? -2.5699 (-1.96%)
Volume: 13,888 @11/23/20 9:37:41 AM EST
Bid Ask Day's Range
128.65 129.12 128.6 - 132.01
SRPT Detailed Quote
News: $SRPT Sarepta Therapeutics Announces Partnership with Roche in Territories Outside the United States for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy, SRP-9001
– Roche obtains the exclusive right to launch and commercialize SRP-9001 outside the United States – – At closing, Sarepta will receive an upfront payment of $1.15 billion, comprising $750 million in cash and $400 million in Sarepta stock, priced at $158.59 per sh...
Got this from SRPT - Sarepta Therapeutics Announces Partnership with Roche in Territories Outside the United States for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy, SRP-9001
No thanks. I try to avoid stocks that have pumpers coming to other
boards to hype their stock.
Last I looked CVM had their own board?
"CONGRATS on your success
We $CVM Shareholders are so happy for you. We have our very own website and a page dedicated to YOU!
Visit KillCVMShorts.com/SRPT
Join our party...its starting soon!
CONGRATS on your success
We $CVM Shareholders are so happy for you. We have our very own website and a page dedicated to YOU!
Visit KillCVMShorts.com/SRPT
Join our party...its starting soon!
Vyondys 53 approval is great news, but can a $2.7B cap increase be
justified or sustained?
I'm thinking there will be a pullback before it moves higher again?
https://www.marketwatch.com/story/sareptas-surprise-fda-approval-for-rare-disease-drug-excites-investors-2019-12-13?siteid=yhoof2&yptr=yahoo
News: $SRPT Sarepta Therapeutics Announces $250 Million of Non-Dilutive Senior Secured Loan Financing
CAMBRIDGE, Mass., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, announced today that it has entered into an agreement with funds managed by Pharmakon Advisors, LP, that provides Sarepta with up to $500...
Read the whole news SRPT - Sarepta Therapeutics Announces $250 Million of Non-Dilutive Senior Secured Loan Financing
$SRPT bulls and bears Sarepta Therapeutics Inc Nasdaq Srpt Short Squeeze
Followers
|
127
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3058
|
Created
|
11/16/05
|
Type
|
Free
|
Moderators |
http://www.sareptatherapeutics.com/
http://www.antivirals.com/
http://finance.yahoo.com/q/h?s=AVII
http://www.form4oracle.com/company?cik=0000873303&ticker=avii
http://www.secform4.com/insider-trading/873303.htm
Sarepta Therapeutics - formerly AVI BioPharma - remains focused on developing first-in-class, RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. Sarepta's unique technology has yielded a diverse pipeline of RNA-based therapeutics that include our lead clinical candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy, a debilitating and life-threatening genetic disorder, as well as potential treatments for some of the world's most lethal infectious diseases.
Our exceptional science- and commercialization-focused team is committed to realizing our vision of becoming a leading, independent biotechnology company dedicated to translating our RNA-based science into transformational therapeutics and, most importantly, bringing these novel therapeutics to patients who have no other options.
AVI BioPharma, Inc., a biopharmaceutical company, develops therapeutic products principally based on NEUGENE antisense technology. It offers various drugs for the treatment of cardiovascular diseases, infectious diseases, cancer, and polycystic kidney diseases, as well as for regulating drug metabolism. The company has collaboration agreement with Chiron Corporation for research, development, and commercialization of antisense therapeutics against hepatitis C virus; Cook Group Incorporated for the development and commercialization of products for vascular diseases; and Ercole Biotech, Inc. to identify and develop drugs that direct the splicing of messenger RNA to treat a range of genetic and acquired diseases. AVI BioPharma was founded in 1980 and is based in Portland, Oregon.
Form Type | Received | Period Ending | Size | Report |
---|---|---|---|---|
PRE 14A | May 16, 2016 | Jun 27, 2016 | 2.7 MB | PDF RTF HTML XLS |
SC 13G | May 6, 2016 | 14.4 KB | PDF RTF HTML XLS | |
8-K | May 5, 2016 | May 5, 2016 | 72.4 KB | PDF RTF HTML XLS |
10-Q | May 5, 2016 | Mar 31, 2016 | 5.0 MB | PDF RTF HTML XLS |
10-K/A | Apr 29, 2016 | Dec 31, 2015 | 2.0 MB | PDF RTF HTML XLS |
4 | Apr 22, 2016 | Apr 20, 2016 | 5.0 KB | PDF RTF HTML XLS |
4 | Mar 17, 2016 | Mar 14, 2016 | 7.4 KB | PDF RTF HTML XLS |
4 | Mar 17, 2016 | Mar 14, 2016 | 5.2 KB | PDF RTF HTML XLS |
4 | Mar 17, 2016 | Mar 14, 2016 | 4.7 KB | PDF RTF HTML XLS |
8-K | Mar 8, 2016 | Mar 7, 2016 | 30.8 KB | PDF RTF HTML XLS |
Phone and email address..................Lead investigator in the DMD trial.....London College of Medicine
http://www1.imperial.ac.uk/medicine/people/f.muntoni/
DISCLAIMER:
•The Board Monitor and The Board Assistants herewith, Are not licensed brokers and assume NO Responsibility for the Actions,
Investment decisions, and or Messages Posted on this Forum.
•We do NOT recommend that Anyone Buy or Sell any Securities Posted Herewith.
Any Trade entered into Risks the Possibility of Losing the Funds Invested.
•There are NO Guarantees when Buying or Selling Any Security.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |